Abstract:Wenmei Zhou, 1 Tao Tao, 1 Wenfeng Yu, 2 Wanfu Wu, 3 Zhirong Hui, 1 Hongliang Xu, 1 Yaqi Li, 4 Ying Zhang, 5 Xiaohui Yang 1, 6 1 Department of Rehabilitation Medicine, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, People's Republic of China; 2 Department of Human Anatomy, Basic Medical College, Guizhou Medical University, Guiyang, Guizhou, 550004, People's Republic of China; 3 Department of Biology and Biochemistry, University of Houston, Houston, TX, 77204, USA; 4 Emergency Department, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, People's Republic of China; 5 Department of Chinese Traditional Medicine, Zunyi Medical and Pharmaceutical College, Zunyi, Guizhou, 563006, People's Republic of China; 6 Department of Rehabilitation Medicine, The Affiliated Hospital Guizhou Medical University, Guiyang, Guizhou, 550001, People's Republic of China Correspondence: Tao Tao, Tel +86 13985162824, Email Background: Hypoxia inducible factor-1α (HIF-1α) regulates glucose metabolism during ischemia. This study investigated the effect of recombinant adenovirus HIF-1ɑ on neurological function and energy metabolism in a rat cerebral ischemia-reperfusion model. Methods: Rats were divided into four groups: sham-operated (Sham) group, cerebral ischemia-reperfusion (CIR) group, recombinant adenovirus empty vector (Ad) group, and recombinant adenovirus-mediated HIF-1α (AdHIF-1α) group. The AdHIF-1α group and the Ad group were injected with AdHIF-1α and Ad in the lateral ventricle. The mNSS was performed at post-ischemia day 0 (P0) and P1, P14 and P28. At P14, the cerebral infarct volume was compared. At P28, HE staining, Nissl stains and TUNEL staining were performed. The expression of HIF-1α, GLUT1 and PFKFB3 were evaluated by Western Blot and immunohistochemistry. High performance liquid chromatography (HPLC) was used to determine the expression of GLUT1 and PFKFB3, and the level of energy metabolites: ATP, ADP and AMP. Results: mNSS scores in the AdHIF-1α group were consistently lower than those in the CIR and Ad groups from P14 (P < 0.05) and Ad groups (P < 0.05). The cerebral infarct volume was reduced in the AdHIF-1α group compared with that in CIR group and Ad group (P < 0.05). At P28, HE showed better pathological changes in AdHIF-1α group. The number of Nissl bodies was increased in the AdHIF-1α group compared with the CIR and Ad groups (P < 0.05). The number of apoptotic cells in the AdHIF-1α group was fewer than that in the CIR and Ad groups (P < 0.05). The expression of HIF-1α, GLUT1 and PFKFB3 was significantly higher in the AdHIF-1α group compared with the CIR and Ad groups (P < 0.05). The ATP, ADP and AMP in the ischemic penumbra were also higher in the AdHIF-1α group (P < 0.05). Conclusion: HIF-lα promoted neurological function recovery and decreased cerebral infarct volume in rats after cerebral ischemia-reperfusion injury by improving energy metabolism. Keywords: cerebral ischemia-reperfusion injury, HIF-lα, energy metabolism, glucose transporter protein-1, GLUT1, 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3, PFKFB3 To restore the cerebral blood supply to the ischemic area in the time window is one of the key treatments for cerebral ischemia. In recent years, the mortality rate of cerebral ischemia has sharply decreased with the popularization of thrombolysis and endovascular techniques. However, reperfusion after ischemia may further aggravate the damage to the ischemic brain tissue and lead to neurological dysfunction due to the sudden increase of oxygen while increasing the blood oxygen supply, which is defined as cerebral ischemia-reperfusion injury (CIRI). 1 CIRI is a pathological phenomenon caused by cerebral ischemic stroke. Hypoxia-inducible factor-1α (HIF-1α) is the initiator that triggers endogenous protection pathways during hypoxia and ischemia by promoting angiogenesis, increasing erythrocytes, promoting cell migration, and inhibiting apoptosis by regulating the expression of its target genes. 2 Our group has successfully constructed recombinant adenovirus-mediated hypoxia inducible factor-1 alpha (AdHIF-1α) and demonstrated that the recombinant adenovirus could be successfully introduced into the lateral ventricle. The treatment of AdHIF-1α in tMCAO rat model showed neuroprotection by decreasing apoptosis of neuronal cells. 3,4 Increasing the expression of endogenous HIF-1α during cerebral ischemia can improve motor and cognitive functions in rats, 5,6 but the cerebral protective mechanisms of HIF-1α need further investigation. Previous studies have sh -Abstract Truncated-

Adrenomedullin Gene Delivery Protects Against Cerebral Ischemic Injury by Promoting Astrocyte Migration and Survival.

Postischemic Infusion of Adrenomedullin Protects Against Ischemic Stroke by Inhibiting Apoptosis and Promoting Angiogenesis

Adrenomedullin Protects Against Myocardial Apoptosis after Ischemia/Reperfusion Through Activation of Akt-GSK Signaling

Recombinant adenoviral vector-mediated gene transfer of angiogenin enhances brain repair following ischemia-reperfusion injury in rat

Mesencephalic astrocyte-derived neurotrophic factor affords neuroprotection to early brain injury induced by subarachnoid hemorrhage via activating Akt-dependent prosurvival pathway and defending blood-brain barrier integrity.

Inhibition of adenosine monophosphate-activated protein kinase reduces glial cell-mediated inflammation and induces the expression of Cx43 in astroglias after cerebral ischemia.

Delayed Treatment with Nicotinamide Inhibits Brain Energy Depletion, Improves Cerebral Microperfusion, Reduces Brain Infarct Volume, but Does Not Alter Neurobehavioral Outcome Following Permanent Focal Cerebral Ischemia in Sprague Dawley Rats

Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice.

Recombinant Adenovirus-Mediated HIF-lα Ameliorates Neurological Dysfunction by Improving Energy Metabolism in Ischemic Penumbra After Cerebral Ischemia-Reperfusion in Rats

Neuronal Nampt is Released after Cerebral Ischemia and Protects Against White Matter Injury

AMELIORATION OF CARDIAC FUNCTION IN CHRONIC MYOCARDIAL INFARCTED RATS FOLLOWING ADMINISTRATION OF VECTOR Pcdna3.1am

[Effects of AMG-1 on Energy Metabolism and Neuronal Damage of Ischemic Brain in Mice and Rats].

Globular Adiponectin Elicits Neuroprotection by Inhibiting NADPH Oxidase-Mediated Oxidative Damage in Ischemic Stroke.

Protective Effect of Ad-VEGF-Bone Mesenchymal Stem Cells on Cerebral Infarction.

Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model

Improvement of Deficits by Transplantation of Lentiviral Vector-Modified Human Amniotic Mesenchymal Cells after Cerebral Ischemia in Rats.

Mesencephalic astrocyte-derived neurotrophic factor prevents neuron loss via inhibiting ischemia-induced apoptosis

Adenovirus-mediated VEGF165 Gene Transfer Has Neuroprotective Effects in Neonatal Rats Following Hypoxic-Ischemic Brain Damage

The Myocardial Response to Adrenomedullin Involves Increased Camp Generation As Well As Augmented Akt Phosphorylation

Tail Vein Infusion of Adipose-Derived Mesenchymal Stem Cell Alleviated Inflammatory Response and Improved Blood Brain Barrier Condition by Suppressing Endoplasmic Reticulum Stress in a Middle Cerebral Artery Occlusion Rat Model

Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion